Abuse Liability for Four Heated Tobacco Product (HTP) Consumables and Two HTP Devices

NCT07267195 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2025-12-16

No results posted yet for this study

Summary

This is a single-site, open-label, randomized, 8-way crossover study designed to evaluate elements of abuse liability (AL), including subjective effects and physiological measures (pharmacodynamics \[PD\]) and plasma nicotine uptake (pharmacokinetics \[PK\]), during and following ad libitum use of the study investigational products (IPs) by generally healthy adult smokers.

Conditions

  • Smoking
  • Smoking Behaviors
  • Tobacco Use
  • Tobacco Smoking

Interventions

OTHER

Product A

Usual Brand filtered, non-menthol /menthol combustible cigarette

OTHER

Product N

Nicorette White Ice Mint 4 mg

OTHER

Product B

Signature Tobacco, Standard Mode, Device 1

OTHER

Product C

Signature Tobacco, Boost Mode, Device 1

OTHER

Product D

Roasted Tobacco, Standard Mode, Device 1

OTHER

Product E

Signature Tobacco, Standard Mode, Device 2

OTHER

Product F

Signature Tobacco, Boost Mode, Device 2

OTHER

Product G

Roasted Tobacco, Standard Mode, Device 2

OTHER

Product H

Fresh Menthol, Standard Mode, Device 1

OTHER

Product I

Fresh Menthol, Boost Mode, Device 1

OTHER

Product J

Menthol Capsule (Crushed), Standard Mode, Device 1

OTHER

Product K

Fresh Menthol, Standard Mode, Device 2

OTHER

Product L

Fresh Menthol, Boost Mode, Device 2

OTHER

Product M

Menthol Capsule (Crushed), Standard Mode, Device 2

Sponsors & Collaborators

  • RAI Services Company

    lead INDUSTRY

Principal Investigators

  • Brian Keyser · Reynolds American

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
21 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-01-31
Primary Completion
2026-06-30
Completion
2026-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07267195 on ClinicalTrials.gov